Zevra Therapeutics
ZVRA
ZVRA
161 hedge funds and large institutions have $379M invested in Zevra Therapeutics in 2025 Q3 according to their latest regulatory filings, with 54 funds opening new positions, 50 increasing their positions, 37 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
19% more capital invested
Capital invested by funds: $319M → $379M (+$60.5M)
4.89% more ownership
Funds ownership: 66.14% → 71.03% (+4.9%)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
Holders
161
Holding in Top 10
4
Calls
$24.8M
Puts
$12.8M
Top Buyers
| 1 | +$9.93M | |
| 2 | +$8.68M | |
| 3 | +$6.57M | |
| 4 |
D.E. Shaw & Co
New York
|
+$5.1M |
| 5 |
CM
Caption Management
Oklahoma City,
Oklahoma
|
+$4.85M |
Top Sellers
| 1 | -$18.5M | |
| 2 | -$17.3M | |
| 3 | -$10.8M | |
| 4 |
VCIM
Velan Capital Investment Management
Alpharetta,
Georgia
|
-$6.3M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$6.23M |
